Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma

The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on survival rates after resection of hepatocellular carcinoma (HCC) is controversial. The objective of this study was to determine whether serologic evidence of HBV or HCV infection ("hepatitis serology") can predi...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Abdalla, Eddie (author)
مؤلفون آخرون: Pawlik, Timothy (author), Poon, Ronnie (author), Sarmiento, Juan (author), Lkai, Iwao (author), Curley, Steven (author), Nagorney, David (author), Belghiti, Jacques (author), Oi-Lin Ng, Irene (author), Yamaoka, Yoshio (author), Lauwers, Gregory (author), Vauthey, Nicolas (author)
التنسيق: article
منشور في: 2004
الوصول للمادة أونلاين:http://hdl.handle.net/10725/2525
http://dx.doi.org/10.1016/j.gassur.2004.06.013
http://link.springer.com/article/10.1016/j.gassur.2004.06.013
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513458578391041
author Abdalla, Eddie
author2 Pawlik, Timothy
Poon, Ronnie
Sarmiento, Juan
Lkai, Iwao
Curley, Steven
Nagorney, David
Belghiti, Jacques
Oi-Lin Ng, Irene
Yamaoka, Yoshio
Lauwers, Gregory
Vauthey, Nicolas
author2_role author
author
author
author
author
author
author
author
author
author
author
author_facet Abdalla, Eddie
Pawlik, Timothy
Poon, Ronnie
Sarmiento, Juan
Lkai, Iwao
Curley, Steven
Nagorney, David
Belghiti, Jacques
Oi-Lin Ng, Irene
Yamaoka, Yoshio
Lauwers, Gregory
Vauthey, Nicolas
author_role author
dc.creator.none.fl_str_mv Abdalla, Eddie
Pawlik, Timothy
Poon, Ronnie
Sarmiento, Juan
Lkai, Iwao
Curley, Steven
Nagorney, David
Belghiti, Jacques
Oi-Lin Ng, Irene
Yamaoka, Yoshio
Lauwers, Gregory
Vauthey, Nicolas
dc.date.none.fl_str_mv 2004
2015-11-10T15:46:16Z
2015-11-10T15:46:16Z
2015-11-10
dc.identifier.none.fl_str_mv 1091-255X
http://hdl.handle.net/10725/2525
http://dx.doi.org/10.1016/j.gassur.2004.06.013
Pawlik, T. M., Poon, R. T., Abdalla, E. K., Sarmiento, J. M., Ikai, I., Curley, S. A., ... & Vauthey, J. N. (2004). Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. Journal of gastrointestinal surgery, 8(7), 794-805.
http://link.springer.com/article/10.1016/j.gassur.2004.06.013
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Journal of Gastrointestinal Surgery
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on survival rates after resection of hepatocellular carcinoma (HCC) is controversial. The objective of this study was to determine whether serologic evidence of HBV or HCV infection ("hepatitis serology") can predict underlying liver disease, tumor factors, and survival rates in patients with HCC. Using a multicenter international database, we identified 446 patients with complete HBV and HCV serology. One hundred twenty-six patients were negative for HBV and HCV, 163 patients had HBV infection only, 79 patients had HCV infection only, and 78 patients had coinfection with HBV and HCV. Patients with hepatitis were more likely to have tumors smaller than 5 cm and bilateral HCC involvement. Hepatitis status (negative vs. HBV vs. HCV vs. coinfection with HBV and HCV) did not predict tumor grade or the presence of multiple tumor nodules. Patients with HCV or coinfection with HBV and HCV exhibited a lower incidence of vascular invasion, but worse fibrosis than patients with negative serology or HBV. The median survival rate was 47.9 months. The presence of hepatitis did not significantly affect the survival rate, but hepatic fibrosis and vascular invasion predicted a decreased survival rate. The prognosis after resection of HCC is influenced by tumor factors and liver disease, but not by HBV or HCV infection. The treatment for HCC should be dictated by the extent of underlying liver disease rather than by hepatitis serology.
eu_rights_str_mv openAccess
format article
id LAURepo_67b5168e8eb8a9cd9e6f574e375db95e
identifier_str_mv 1091-255X
Pawlik, T. M., Poon, R. T., Abdalla, E. K., Sarmiento, J. M., Ikai, I., Curley, S. A., ... & Vauthey, J. N. (2004). Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. Journal of gastrointestinal surgery, 8(7), 794-805.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/2525
publishDate 2004
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinomaAbdalla, EddiePawlik, TimothyPoon, RonnieSarmiento, JuanLkai, IwaoCurley, StevenNagorney, DavidBelghiti, JacquesOi-Lin Ng, IreneYamaoka, YoshioLauwers, GregoryVauthey, NicolasThe impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on survival rates after resection of hepatocellular carcinoma (HCC) is controversial. The objective of this study was to determine whether serologic evidence of HBV or HCV infection ("hepatitis serology") can predict underlying liver disease, tumor factors, and survival rates in patients with HCC. Using a multicenter international database, we identified 446 patients with complete HBV and HCV serology. One hundred twenty-six patients were negative for HBV and HCV, 163 patients had HBV infection only, 79 patients had HCV infection only, and 78 patients had coinfection with HBV and HCV. Patients with hepatitis were more likely to have tumors smaller than 5 cm and bilateral HCC involvement. Hepatitis status (negative vs. HBV vs. HCV vs. coinfection with HBV and HCV) did not predict tumor grade or the presence of multiple tumor nodules. Patients with HCV or coinfection with HBV and HCV exhibited a lower incidence of vascular invasion, but worse fibrosis than patients with negative serology or HBV. The median survival rate was 47.9 months. The presence of hepatitis did not significantly affect the survival rate, but hepatic fibrosis and vascular invasion predicted a decreased survival rate. The prognosis after resection of HCC is influenced by tumor factors and liver disease, but not by HBV or HCV infection. The treatment for HCC should be dictated by the extent of underlying liver disease rather than by hepatitis serology.PublishedN/A2015-11-10T15:46:16Z2015-11-10T15:46:16Z20042015-11-10Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1091-255Xhttp://hdl.handle.net/10725/2525http://dx.doi.org/10.1016/j.gassur.2004.06.013Pawlik, T. M., Poon, R. T., Abdalla, E. K., Sarmiento, J. M., Ikai, I., Curley, S. A., ... & Vauthey, J. N. (2004). Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. Journal of gastrointestinal surgery, 8(7), 794-805.http://link.springer.com/article/10.1016/j.gassur.2004.06.013enJournal of Gastrointestinal Surgeryinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/25252019-02-26T09:34:42Z
spellingShingle Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
Abdalla, Eddie
status_str publishedVersion
title Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
title_full Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
title_fullStr Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
title_full_unstemmed Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
title_short Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
title_sort Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
url http://hdl.handle.net/10725/2525
http://dx.doi.org/10.1016/j.gassur.2004.06.013
http://link.springer.com/article/10.1016/j.gassur.2004.06.013